Peter Greenleaf
Known title: DirectorCIK: 0001363683
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
AUPH Appears in Report on Activist Investor Activity. Aurinia Pharmaceuticals was mentioned among stocks drawing attention from activist investors, according to recent financial news coverage. No specific activist involvement details or corporate action plans were detailed in the report. The stock is currently trading between its 52-week range extremes, with analysts maintaining price targets notably above current levels.
Transaction History
| PTHS | ▼ Sell | Open Market | 797 | $17K | 10/2/2026 | View on chart |
| PTHS | ▼ Sell | Open Market | 712 | $19K | 7/2/2026 | View on chart |
| PTHS | ▼ Sell | Open Market | 85 | $2K | 7/2/2026 | View on chart |
| PTHS | ▼ Sell | Open Market | 420 | $9K | 4/2/2026 | View on chart |
| PTHS | ▼ Sell | Open Market | 377 | $8K | 4/2/2026 | View on chart |
| AUPH | ▼ Sell | Tax Withholding | 100,890 | $1.4M | 3/2/2026 | View on chart |
| AUPH | ▲ Buy | Grant | 196,403 | $0 | 2/27/2026 | View on chart |
| AUPH | ▼ Sell | Tax Withholding | 100,171 | $1.4M | 2/20/2026 | View on chart |
| AUPH | ▲ Buy | Grant | 165,384 | $0 | 1/2/2026 | View on chart |
| AUPH | ▼ Sell | Tax Withholding | 113,169 | $1.8M | 1/2/2026 | View on chart |
| AUPH | ▼ Sell | Open Market | 164,947 | $1.3M | 3/4/2025 | View on chart |
| AUPH | ▲ Buy | Grant | 333,705 | $0 | 3/3/2025 | View on chart |
| AUPH | ▼ Sell | Open Market | 195,593 | $1.6M | 3/3/2025 | View on chart |
| AUPH | ▲ Buy | Grant | 290,728 | $0 | 2/28/2025 | View on chart |
| AUPH | ▼ Sell | Open Market | 126,981 | $711K | 3/6/2024 | View on chart |
| AUPH | ▲ Buy | Grant | 661,538 | $0 | 2/20/2024 | View on chart |
| AUPH | ▲ Buy | Grant | 667,407 | — | 3/2/2023 | View on chart |
| AUPH | ▼ Sell | Open Market | 32,750 | $293K | 3/2/2023 | View on chart |
| AUPH | ▲ Buy | Grant | 28,300 | $0 | 3/2/2022 | View on chart |
| AUPH | ▼ Sell | Open Market | 9,068 | $109K | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Pelthos Expands Coverage for ZELSUVMI Topical Gel
Pelthos Therapeutics announced that its topical gel ZELSUVMI® will now be covered by more insurance plans. The broader formulary coverage could make the product more accessible to patients. This change may support the company’s sales growth for the drug. The update follows the company’s recent progress in bringing the therapy to market.
Pelthos Expands Coverage for ZELSUVMI Topical Gel. Pelthos Therapeutics announced that its topical gel ZELSUVMI® will now be covered by more insurance plans. The broader formulary coverage could make the product more accessible to patients. This change may support the company’s sales growth for the drug. The update follows the company’s recent progress in bringing the therapy to market.